Courts have ruled in favour of a teenager who wants medical treatment in his gender transition, despite the opposition of his father, in a ruling that grants trans kids more legal rights and protections.
People living with HIV who belong to marginalized communities and have faced discriminatory or unwelcome behaviour at public health centres, have a reason to cheer.
A combination of two long-acting injectable anti-HIV drugs taken once monthly had a very low rate of treatment failure and a favourable safety profile,
When taken daily, emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP) has a high success rate of preventing HIV infection.
Scientists have long tried to duplicate the procedure that led to the first long-term remission 12 years ago. With the so-called London patient, they seem to have succeeded.
